Blood transfusions, fluid therapy, SIRS. Ch 2-4 Flashcards

(34 cards)

1
Q

Clinical indications for blood transfusion (4)

A

PCV <20% (remembering PCV may not fall until at least 12hrs)

Estimated 30% or more blood loss

Oxygen extraction ratio >50%

Lactate >4mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Equine blood volume

A

8% bodyweight ie 40L in a 500kg horse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Blood donation volume

A

Maximum 20% of blood volume (ie 8L in 500kg horse)

Replacement IVFT is recommended if >15% blood volume taken

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood transfusion equation based on PVC

A

Transfusion volume (L) = bodywt x 0.08 x (desired PCV-actual PVC)

donor PCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Equation to calculate amount of plasma to be transfused

A

Bwt x 0.045 x (desired TP - actual TP)

donor TP

Same as for blood transfusion except times by 0.045 vs 0.08 (blood volume vs plasma volume)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Oxygen extraction ratio

A

O2 ER = PaO2 - PVO2

PaO2

Transfusion required at >50% - ie if venous blood is very deoxygenated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ideal blood donor

A

Large gelding with no previous blood transfusion

Negative for Aa and Qa alloantigens - these are the two most likely associated with transfusion reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Red blood cell half life of allogenic and autogenous red cells collected 24hr previously

A

20 days allogenic

45 days autogenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Major crossmatch

A

Detects agglutination between donor red cells and recipient serum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Minor crossmatch

A

Detects agglutination between donor serum and recipients red cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Blood storage times

A

Can store whole blood in CPDA-1 for 28days (says upto 21d in a fridge at 1-6’C in Slatter)

Packed red cells for 35d (not recommended in humans - higher mortality vs whole blood)

(Says 21d in Slatter with CPDA-1 and longer if red cell additive used)

FFP - upto 1 year at -18’C. Upto 3 months in normal household freezer

FP - 4 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Distribution of total body water

A

60% of body weight

66% intracellular

33% extracellular

ECF divided into interstitial (75%) and intravascular (25%)

IV fluid compartment is the smallest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Difference between fresh frozen plasma and frozen plasma

A

FFP is plasma separated and frozen at -18’C within 8 hours of collection

FP is either FFP after 1 year of frozen storage (it is then useable as FP for 4 years at -18) or blood that has been separated and stored >8hours after collection

Frozen plasma products maintain factors II, VII, IX and X (also the vit K dependent factors) and albumin and Igs. BUT LACK factors V, VIII and von Willebrand factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Administration of packed red cells

A

Last refrigerated at least 21 days with CPDA-1

Ideally leave with some plasma such that PCV <80%. Agitate daily

To administer, resuspend with 0.9%NaCl. Calcium containing fluids incl Hartmanns should NOT be used - can cause coagulation

(says 10ml saline per 30-40ml red cells in slatter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Components of primary haemostasis

A

Local vasoconstricton

vWF factor release from endothelial cells (Weibel-Pallade bodies)

Platelet attraction, activation and adhesion (the 3 a’s)

The interaction of activated platelets with the exposed subendothelium of blood vessels is the basis of primary hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Role of platelets in secondary haemostasis

A

Once activated, they undergo conformational change exposing binding sites for specific coagulation factors

17
Q

How is platelet adhesion mediated

A

Through expression of P-selectin on activated (damaged) vascular endothelium and through the platelet receptor GPIbα, which attaches to vWF

18
Q

Definition of SIRS

A

Inappropriate generalised inflammatory response to tissue damage/infection w mechanisms intended to defend & repair; but exaggerated systemic reaction rx in clinical state of SIRS - can be more detrimental than the initial insut itself

19
Q

List 5 pro-inflammatoy cytokines

A

IL-1

IL-6

IL-8

TNF-∝

IFN-𝛾

20
Q

List 5 (predominantly) anti-inflammatory cytokines (NB some X-over in pro/anti-inflammatory function)

A

IL-4

IL-10

IL-11

IL-13

TGF-β

21
Q

Briefly describe the arachadonic acid cascade

A
  • AA rx from membrane phosopholipid through the action of PLA2
  • AA is metabolised via COX and LOX pathways to generate eicosanoids
  • Eicosanoids comprise leucotrines (LOX) and prostanoids (COX) = prostaglangins and thromboxane A2
22
Q

What are the 2 main acute phase proteins in horses?

A

SAA

C-reactive protein (role in complement activation)

Colletively responsible for many of the effects incl pyrexia, anorexia and depression

Synthesised in the liver; ↑in response to IL-1,6 & TNF

23
Q

Briefly describe the complement system

A

Functions to enhance immune defense (phagocytosis and antibody function) against pathogens. Part of the innate immune system but can be stimulated by the adaptve (AG-AB complexes)

Several inactive protein precursors (synthesised in the liver); when activated they induce bacteriolysis, ↑vascular permeability, ↑neut chemotaxis & ↑opsonisation (susceptibility to phagocytosis) of microbes and damaged cells

24
Q

List the diagnostic criteria for SIRS in adults (3)

A
  1. Rectal temp: >38.5°C of <37°C
  2. HR >52bpm
  3. WBC count: >12.5 or <5x109/L, or >10% bands

Addition of lactate >2.06mmol/L and abnormal mm colour may be useful

Can make a dx when 2 or more are satisfied

25
Key considerations in sepsis scoring for neonates
Scoring of 0-4 for 14 parameters **HISTORY** - 1. placentitis? Y=3/N=0 2. Gestation length - \<300=3, 300-310=2, 311-330=1 \>330=0 **PE**: 3. Petechiae/scleral injection 4. Fever - 5. Hypotonia, coma, seizure - Marked=2, mild=1 6. Anterior uv, d+, ARDS, joint effusions - Y=3, N=0 **LAB**: 7. Neuts - \<2=3, 2-4 or \>12=2, 8-12=1 8. Band neuts/µL - \>200=3, 50-200=2 9. Toxic neuts - Marked=4, mod=3, mild=2, none=0 10. Fib - \>600=2, 4-600 =1, \<400=0 11. Glucose - \<50=2, 50-80=1, \>80=0 12. IgG - \<200=4, 2-400 =3, 4-800=3, \>800=0 13. PaO2 - \<40=3, 40-50=2, 50-70=1, \>70=0 14. Metabolic acidosis - Y=1, N=0 **TOTAL SCORE ≥11 IS PREDICTIVE OF SEPSIS** (or use cutoff of 12 if PaO2 and metabolic acidosis are included)
26
Definition of MODS
Altered organ function in acutely ill patient such that homeostasis cannot be maintained
27
Diagnostic criteria for MODS
No equine consensus. Various human scoring systems, none really validated in EQ other than 1 in surgical colics only (JVIM 2016) - **score \>8 on d1 and \>6 on d2 assoc w nonsurvival** Looks at lab parameters from 8 organ/systems
28
Obel laminitis grading
Graded 0-4 (0=normal) 1 - Normal walk, stilted trot but no obv head not 2 - Stilted walk, obv lameness at trot but can easily lift limbs 3 - Lameness obvious at walk, reluctant to lift limb(s) 4 - Marked lameness, difficulty weight bearing and reluctant to move
29
What is the main mechanism of innate immunity
* Via pattern recognition receptors (PRRs) which detect pathogen associated molecular patterns (PAMPs); evolutionary conserved molecules unique to microbes, usually essential for their survival/virulence * 3 main types of mammalian PRRs incl 1) secreted PRRs, incl defensins; (2) cell membrane PRRs involved in phagocytosis; and (3) cell membrane PRRs involved in signal transduction * PAMPs incl bacterial cell wall extracts (LPS), peptidoglycan, prokaryotic DNA
30
Structure of endotoxin
3 main domains 1. Lipid A 2. Core polysaccharide 3. O antigen _Variation in no/length of FAs on glucosamine disaccharide backbone of lipid A confers degree of toxicity_
31
What is the main source of endotoxin
Large pool of GRAM NEGATIVE gut bacteria - LPS is major component of their outer membrane. Endotoxin must gain access to circulation to exert toxic effect
32
Cellular steps in pathophysiology of endotoxaemia
* Lipopolysaccharide binding protein (LBP) (acute phase protein) binds LPS & extracts it from aggregated micelles in the blood - transport to various sites which determines host response in large part - [LBP] can ↑\>100fold in 24hr * Can be transported to the cell surface of host inflammatory cells to evoke inflamm response or can be transferred to other neutralising lipoproteins, such as high-density lipoprotein, for eventual removal from the blood * Once at the cell surface, LPS is transferred to **CD14**, expressed by monocytes/macrophages - membrane and soluble CD14 -can bind/neutralise LPS * Conversely CD14 can also potentiate toxic effects of endotoxins, by transferring it to membrane CD14 or to cells that do not express it. * CD14 does not structurally cross the cell membrane; has to associate w 2ary protein, toll-like receptor (TLR), that contains a transmembrane portion capable of comms w intracellular domain. * TLR-4 is mandatory for responsiveness to endotoxin * Once the CD14-TLR4-endotoxin complex is compiled at the cell surface, TLR-4 req help of a 160–amino acid molecule, MD2, to transmit a signal to the cytosol → intracellular signalling pathways incl NF𝞳B ⇒ stimulates inflamm response * Most of the deleterious effects of endotoxin rx from overzealous endogenous synthesis of pro-inflammatory mediators and initiation of SIRS - AA metabolites most widely studied
33
Management of endotoxaemia
2 therapeutic options * **Polymixin B** - a cationic antibiotic that has bacteriocidal properties & binds/neutralises endotoxin through direct interaction with lipid A (highly conserved so PB theoretically has broader endotoxin-binding capabilities than anticore-endotoxin antibodies) * Can be stored at room temp. Does have inherent nephrotoxic and neurotoxic side effects when used IV at bactericidal doses, but for neutralisation, sub-bactericidal doses are efficacious without toxicity; recommended dose is 1000-6000IU/kg q 8-12hrs, care w azotaemic patients nonetheless. Effect is dose dependent, use higher end of dose range if ↑endotoxin anticipated * **2) Anti-endotoxin antibodies** - anticore antibodies have conflictin rx. Endoserum = hyperimmune serum from horses vacc w Salmonella typhimurium, Re mutant. Disadv of requiring refrigeration. Dilutied w sterile isotonic saline or LRS (1:10 to 1:20) and administered IV over 1-2 hr to reduce risk hypersensitivity reactions. * Hyperimmune anticore plasma to Escherichia coli J5 (Equiplas) can be used in foals for concurrent tx of endotoxemia, septicemia, & FPT, given at 20-40 ml/kg, or in adults. * Plasma products are expensive, req freezer storage, ∴ need thawed * Others incl **flunixin** - 0.25 mg/kg IV q 8 hr is commonplace; benefit of this low-dose incl reduced risk of potential toxic side effects (not cited elsewhere)
34
Approximate % blood volume in adults and neonates
8% adults, upto 14% in fit horses 15% in neonates